再生障碍性贫血患者Fas+/CD8+细胞减少

再生障碍性贫血(aplstic anemia,aa)是一组以全血细胞减少和骨髓低增生为特征的综合征,其确切的发病机制尚未明确,但免疫异常特别是T淋巴细胞数量和功能的异常在发病中的作用却越来越受到重视。在正常的免疫反应中,淋巴细胞会在不同的阶段全部死亡,而Fas／FasL系统在T淋巴细胞的清除过程中发挥着主导性作用。     

再生障碍性贫血患者CD34+与T淋巴细胞亚群CD45RA+、CD45RO+表达的相关性研究

再生障碍性贫血（Aplastic anemia，从，简称再障）是一种获得性骨髓造血功能衰竭症。近年来研究发现免疫系统紊乱与再障的发生密切相关，某些药物、化学毒物、病毒感染等都是再障的病因，但不管再障的初始病因如何，免疫系统对造血系统的损伤在再障的发病过程中起核心作用。CD45抗原是白细胞分化抗原，在细胞的生长、增殖、功能活化等过程中具有重要的作用。CIM5RA、CIM5RO是CIM5分子的两类亚型，分别代表初始／活化T细胞，有关CD45表达与AA的发病机制的研究尚未见于国内外报道。     

Fas抗原在急性再生障碍性贫血患者血清和骨髓CD34^＋细胞中的表达

造血干细胞数量减少和功能异常系再生障碍性贫血（AA）的发病基础,最近体外研究发现,γ-干扰素（IFN-γ）和肿瘤坏死因子α（TNF-α）可上调介导细胞调亡的膜型Fas（mFas）抗原在骨髓CD34＋细胞膜表面的表达,提示细胞调亡可能参与了AA的发病。AA患者骨髓CD34 细胞是否过度表达mFas抗原,血清中是否存在可溶性Fas（aFas）抗原,国内尚未见报道,本文对此进行了初步探讨。1材料和方法1．1研究对象20例符合急性再生障碍性贫血（AAA）诊断标准的患者。其中男性12例,女性8例,年龄18～48岁,中位年龄29岁,此前均未曾输血。以10例…     

再生障碍性贫血患者T细胞CD69的表达

CD69又称活化诱导分子（AIM）、早期活化抗原1（EA-1），是淋巴细胞活化最早表达的膜表面分子。CD69由两个相同的单体经不同的糖基化后构成，属植物血凝素C超家族Ⅱ型膜贯通型糖蛋白，细胞外区C型凝集素（钙离子依赖性）有一个N结合型糖链附着部位。静止状态的T细胞不表达CD69，     

分泌细胞因子的CD8^＋T细胞亚群研究进展

Ｔ细胞具有功能不同的亚群，其中ＣＤ４＾＋辅助Ｔ细胞（ＴＨ）的亚群分类及功能早已成定论。近几年的研究发现传统的ＣＤ８＾＋细胞毒Ｔ细胞（ＣＴＬ）也可分泌与ＣＤ４＾＋Ｔ细胞相似的细胞因子，也可分为两类亚群，分别定义为Ｔｃ１和Ｔｃ２。本文就近年来这方面的研究进展作一综述。     

慢性再生障碍性贫血患者CD28共刺激分子及Fas的表达

再生障碍性贫(ap]astic anemia,AA)简称再障,是免疫介导的造血抑制的综合病症,其中又以慢性再生障碍性贫血(chronic aplastic anend8,CAA)患者多见.本文旨在观测CAA患者外周血共刺激分子CD28及Fas(CD95)的表达水平.     

再生障碍性贫血患者外周血T细胞亚群和T细胞受体表达水平及其 …

采用流式细胞仪及间接免疫荧光法检测３０例再生障碍性贫血患者外周血中Ｔ细胞亚群及Ｔ细胞表面受体表达水平，并与健康对照组相比，结果表明：７０％再障患者存在ＣＤ４／ＣＤ８比例倒置及ＣＤ８＾＋％异常增高；５０％再障患者外周血γ－δＴ细胞亚群及其在Ｔ淋巴细胞总体中所占比例均显著增高；而αβＴ细胞亚群及ＴｉｒＡ＾＋细胞百分率与正常对照组相比无显著性差异。提示：半数以上再障患者外周血中存在异常增多的γδＴ细胞及     

HIV/AIDS患者CD28在外周血CD4+、CD8+ T细胞上的表达变化

目的　研究国内HIV AIDS患者CD2 8在外周血CD4 + 、CD8+ T淋巴细胞上表达的变化 ,并探讨这些变化的临床意义。方法　用流式细胞仪检测 5 1例正常对照、14例HIV感染者和 36例AIDS患者的外周血CD4 + 、CD8+ T淋巴细胞表面的CD2 8分子的表达 ,用bDNA法检测 11例HIV感染者和 18例AIDS患者的血浆病毒载量。结果　CD4 + CD2 8+ T细胞的绝对计数与百分比、CD8+ CD2 8+T细胞的百分比均显示为正常对照组 >HIV感染组 >AIDS组 ;而CD8+ CD2 8+ T细胞的绝对计数显示HIV感染组和对照组显著大于AIDS组 ,HIV感染组与对照组间差异无显著性。CD4 + 、CD2 8+ CD4 + T淋巴细胞计数与血浆病毒载量显著负相关。结论　HIV AIDS患者外周血CD2 8在CD4 + 、CD8+ T淋巴细胞上表达随着病情进展而降低 ,反映了细胞免疫功能随着疾病进展损害逐渐加重 ,是判断病情进展的指标。     

CD86对CD8+T细胞分化的影响

目的：探讨CD86(B7-2)对CD8^ T细胞分化的影响。方法：用限制性内切酶Xho Ⅰ酶切质粒pCDM8得到CD86基因，并将其插入pCDNA3，用BamH Ⅰ酶切鉴定。用脂质体法介导pCDNA3-CD86真核表达载体转染人肝癌细胞株HMCT／21，600μg/ml G418筛选，稳定且高表达CD86的抗性克隆用流式细胞仪进行鉴定。从健康志愿者血中分离外周血单个核细胞(PB-MC)，使PBMC与靶细胞之比为20：1，共同培养48h后，用流式细胞仪检测CD3^ T细胞内IL-4和IFN-γ的表达率。结果：成功构建pCDNA3-CD86真核表达载体；CD86在HMC7721-CD86细胞中的表达率为30．8％，而在HMC7721细胞中的表达率为0．98％；健康志愿者CD3^ T细胞内IL-4和IFN-γ的表达率分别为1．92％和24．4％；PBMC与靶细胞共同培养48h后，无论是否用IFN-α刺激，IL-4，IFN-γ的阳性比值在HMC7721-CD86转染组均大于1，而在HMC7721未转染组均小于1。结论：在细胞培养中，CD86可诱导CD8^ T细胞活化，并向Tc2表型转化。     

慢性乙型肝炎患者外周血细胞CD40+、CD40L+及CD8+/CD28+表达的研究

目的检测慢性乙型肝炎(简称慢乙肝)患者外周血淋巴、单核细胞表面CD40+、CD40L+及淋巴细胞表面CD8+/CD28+、CD8+/CD28-的表达,评价患者的细胞免疫状态,为临床治疗提供指导.方法流式细胞仪测定慢乙肝患者单核细胞、淋巴细胞表面CD40+、CD40L+表达的百分率及淋巴细胞表面CD8+/CD28+、CD8+/CD28-表达的百分率.结果慢乙肝组外周血淋巴、单核细胞表面CD40+、CD40L+及淋巴细胞表面CD8+/CD28+的表达明显低于正常对照组(P＜0.01,P＜0.05,P＜0.01,P＜0.05,P＜0.01),乙肝肝硬化组(简称肝硬化)均明显低于正常对照组(均P＜0.01),而慢乙肝组、肝硬化组CD8+/CD28-的表达高于正常对照组(P＜0.05,P＜0.01).慢乙肝组与肝硬化组均无显著差异(均P＞0.05).慢乙肝轻、中、重度和肝硬化三组间均无显著差异(均P＞0.05).相关性分析结果显示,慢乙肝患者淋巴、单核细胞表面CD40+和CD40L+的表达之间存在正相关,淋巴细胞CD40+、CD40L+表达与CD8+/CD28+表达存在正相关,而与CD8+/CD28-表达相关性不明显.结论慢乙肝患者外周血淋巴、单核细胞CD40+、CD40L+及淋巴细胞CD8+/CD28+表达低下,而CD8+/CD28-的表达增加.检测外周血CD40+、CD40L+及CD8+/CD28+的表达可评估患者的细胞免疫状态,对临床的抗病毒治疗提供新思路.     

Regulation of CD28 expression on CD8+ T cells by CTLA-4

CD28 and CTLA-4 are the critical costimulatory receptors that predominantly determine the outcome of T cell stimulation, with CD28 promoting positive costimulation and CTLA-4 inducing inhibitory signals. Blockage of the B7-CD28/CTLA-4 pathway leads to transplantation tolerance. However, the exact mechanism of the inhibitory function of CTLA-4 remains elusive. Here, we investigated the influence of CTLA-4 expression on CD28 using CTLA-4-transfected Jurkat T cells as well as primary T cells. Up-regulation of CTLA-4 induced abrogation of IL-2 production, indicating an anergic phenotype of CTLA-4(high) T cells. Besides the negative signaling function of CTLA-4, we show for the first time that CTLA-4 expression promotes the down-regulation of CD28 on the T cell surface as a result of enhanced internalization and degradation of CD28. These data suggest that apart from the established competition for B7.1 and B7.2 by CTLA-4, inhibition of T cells by CTLA-4 might be additionally explained by reduction of CD28 on the cell surface, which might impede T cell response to stimulation. Our data provide a previously unrecognized mechanism for T cell regulation.     

Generation of CD28- cells from long-term-stimulated CD8+CD28+ T cells: a possible mechanism accounting for the increased number of CD8+CD28- T cells in HIV-1-infected patients.

According to CD28 molecule expression, CD8+ T cells can be classed as CD28bright, CD28dim, and CD28-. The CD28dim T cells were found to derive from mitogenic stimulated CD28-T cells but also from CD28bright T cells through a mechanism of CD28 down-modulation. Moreover, after prolonged in vitro interleukin-2 stimulation, clonal CD28bright, cells showed a CD28dim expression before further evolution to a stable CD28-phenotype. This loss was concomitant with the disappearance of CD28 mRNA. A study of the cytokine production pattern revealed that CD28dim and CD28- T cell clones produced similar levels of type 1 and type 2 cytokines, which differed from those produced by the CD28bright T cell clones. A high percentage of CD28dim and CD28- cells, with similarities in their cytokine production pattern, were found in the blood samples of HIV-infected patients, as compared to healthy donors. The CD28 down-modulation may account for the increased number of CD8+CD28- T cells in HIV-infected patients.     

Regulatory CD8+CD28- T cells in heart transplant recipients

Human regulatory CD8+CD28- T cells (Ts) generated in vitro were demonstrated to suppress the activation and proliferation of T helper cells (Th) induced by allogeneic cells. This effect requires cell-to-cell contact, is antigen-specific, and results in Th anergy. To study the population of CD8+CD28- T cells present in vivo, flow cytometry was performed on whole blood specimens obtained from 25 heart transplant recipients and 12 normal controls. A significant expansion of CD8+CD28- T cells was found in transplant recipients as compared with normal individuals (p = 0.005). Expression of CD38, human leukocyte antigen-DR, and perforin positive cells within the CD8+CD28- subset was significantly higher in transplant patients than in normal controls, yet there was no correlation between the expression of these markers and acute rejection. Expression of the CD27 marker, however, was significantly higher within CD8+CD28- T cells from patients without rejection as compared with patients in rejection (p = 0.005), indicating that the memory-like CD8+CD28-CD27+ T-cell subset comprises regulatory cells, which play a protective role for the graft. CD8+CD28- T cells isolated from transplant patients did not display cytotoxic activity against donor cells and showed high expression of the killing inhibitory receptor CD94. This study identifies the phenotypic changes that occur in patients with heart transplants and opens new avenues for the induction of specific immunosuppression in transplantation.     

CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease

Chronic antigenic stimulation leads to gradual accumulation of late-differentiated, antigen-specific, oligoclonal T cells, particularly within the CD8(+) T-cell compartment. They are characterized by critically shortened telomeres, loss of CD28 and/or gain of CD57 expression and are defined as either CD8(+) CD28(-) or CD8(+) CD57(+) T lymphocytes. There is growing evidence that the CD8(+) CD28(-) (CD8(+) CD57(+)) T-cell population plays a significant role in various diseases or conditions, associated with chronic immune activation such as cancer, chronic intracellular infections, chronic alcoholism, some chronic pulmonary diseases, autoimmune diseases, allogeneic transplantation, as well as has a great influence on age-related changes in the immune system status. CD8(+) CD28(-) (CD8(+) CD57(+)) T-cell population is heterogeneous and composed of various functionally competing (cytotoxic and immunosuppressive) subsets thus the overall effect of CD8(+) CD28(-) (CD8(+) CD57(+)) T-cell-mediated immunity depends on the predominance of a particular subset. Many articles claim that CD8(+) CD28(-) (CD8(+) CD57(+)) T cells have lost their proliferative capacity during process of replicative senescence triggered by repeated antigenic stimulation. However recent data indicate that CD8(+) CD28(-) (CD8(+) CD57(+)) T cells can transiently up-regulate telomerase activity and proliferate under certain stimulation conditions. Similarly, conflicting data is provided regarding CD8(+) CD28(-) (CD8(+) CD57(+)) T-cell sensitivity to apoptosis, finally leading to the conclusion that this T-cell population is also heterogeneous in terms of its apoptotic potential. This review provides a comprehensive approach to the CD8(+) CD28(-) (CD8(+) CD57(+)) T-cell population: we describe in detail its origins, molecular and functional characteristics, subsets, role in various diseases or conditions, associated with persistent antigenic stimulation.     

A reduction in the number of peripheral CD28+CD8+T cells in the acute phase of influenza

Influenza patients show a high incidence of T lymphocytopenia in the acute phase of the illness. Since CD8+ T cells play an important role in influenza virus infection, we investigated which subset of CD8+ T cells was involved in this lymphocytopenia. CD8+ T cells from eight patients with influenza A were studied for lymphocyte count, surface marker, and intracellular IFN-gamma production in the acute (days 1-3) and recovery phases (days 9-12). Total and T lymphocyte counts in the acute phase were approximately three times less than in the recovery phase; however, the CD4/8 ratio was the same in both phases. The cell count reduction in the acute phase was attributed predominantly to the CD28+ CD8+ subset, compared with the CD28- CD8+ subset. The memory/activation marker CD45RO on the CD8+ T cells was assessed. The CD28+ CD45RO- subset, a naive phenotype, was reduced significantly in number in the acute phase compared with the recovery phase. The CD28+ CD45RO+ subset, a memory phenotype, was also reduced in the acute phase, but the reduction was not statistically significant. Intracellular IFN-gamma in the CD8+ subset after mitogenic stimulation was measured by flow cytometry; the percentage of CD28+ IFN-gamma-/CD8+ subset in the acute phase was significantly less than in the recovery phase. These results indicated that the predominant reduction of peripheral CD8+ T cells in the acute phase of influenza was from naive-type lymphocytes, suggesting that these quantitative and qualitative changes of CD8+ T cells in influenza are important for understanding the immunological pathogenesis.     

Enhancement of proliferation and downregulation of TRAIL expression on CD8+ T cells by IL-21

Mounting evidence indicates that the cytokine IL-21 can significantly enhance the survival of CD8(+) T lymphocytes. Given that CD4(+) T lymphocytes constitute the main cellular source for IL-21 in vivo, it is tempting to speculate a direct role in mediating the "help" provided by these CD4(+) T cells to the CD8 response. A new report in this issue of the European Journal of Immunology advances this notion by showing that CD8(+) T cells lacking the IL-21 receptor phenocopy those primed in the absence of CD4(+) T cells (the so-called "helpless" CD8(+) T cells) in their induction of the pro-apoptotic factor TRAIL. This finding helps to define the role of IL-21 in the CD8 response, and raises new questions relevant for achieving a broader understanding of this multifunctional cytokine.     

Idiopathic CD4+ T cell lymphocytopenia with the absence of B cells and CD8+28+ cells in peripheral blood

The absence of B cells and a severe decrease in CD8+28+ cells were observed in two female children with CD4+ T cell lymphocytopenia. Idiopathic (primary) CD4+ lymphocytopenia is a rare entity and its pathogenesis and genetics are not yet known. The literature was reviewed, in particular for severe alterations in B and CD8+28+ cells and for the role of NF-kappa B and p56^lck in the immunopathogenesis. Whether the underlying mechanism in idiopathic CD4+ lymphocytopenia is found or not, these patients who present with severe symptoms of a combined immunodeficiency must be treated with intravenous immunoglobin regularly until they have a compatible donor for bone marrow transplantation. Received: 4 May 2001 / Accepted: 10 October 2002 Correspondence to N. Kutukculer     

CD8+ CD28− T cells in vertically HIV-infected children

To evaluate whether vertical HIV infection interferes with the expression of CD28 on T lymphocytes, 25 HIV-infected children and 29 seroreverted children born to HIV⁺ mothers were studied. The percentage of CD28⁻ cells among CD8⁺ T lymphocytes was higher in HIV-infected children than in controls (P < 0.001). In fact, in HIV-infected children, this percentage was elevated from the first year of life, while in healthy seroreverted children, the proportion of CD28⁻ cells among CD8⁺ cells rose progressively with age (r = 0.49; P = 0.008). In HIV⁺ children, the CD8⁺ CD28⁻, but not CD8⁺ CD28⁺ cell proportion was significantly correlated with immunological markers of disease progression, such as CD4⁺ cell loss (r = −0.65; P < 0.001) and the level of in vitro spontaneous lymphocyte apoptosis (r = 0.53; P = 0.03).     

FLIP and FasL expression by inflammatory cells vs thyrocytes can be predictive of chronic inflammation or resolution of autoimmune thyroiditis

Spontaneous autoimmune thyroiditis (SAT) in NOD.H-2h4 mice is a model of chronic inflammation of the thyroid, while granulomatous experimental autoimmune thyroiditis (G-EAT) is a model with spontaneous resolution of inflammation. In chronic inflammation (SAT), Fas, FasL, and FLIP were upregulated and predominant in inflammatory cells. There were few apoptotic cells, and low expression of active caspase-8 and -3. In resolving G-EAT in CBA/J and NOD.H-2h4 mice, FasL and FLIP were predominantly expressed by thyrocytes. There were many apoptotic inflammatory cells, and increased expression of active caspase-8 and -3. Depletion of CD8+ T cells inhibited G-EAT resolution and resulted in chronic inflammation. FLIP was expressed predominantly by inflammatory cells, and apoptosis of inflammatory cells and expression of active caspase-3 was reduced as in chronic SAT. Thus, differences in expression of pro- or antiapoptotic molecules in SAT or G-EAT were apparently related to the acute vs chronic nature of the inflammatory response rather than the method of disease induction. Upregulation of FLIP by inflammatory cells may block Fas-mediated apoptosis, contributing to chronic inflammation, whereas increased FLIP expression by thyrocytes in resolving G-EAT may protect thyrocytes from apoptosis, and FasL expression by thyrocytes may induce apoptosis of inflammatory cells, contributing to resolution.